Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report.

Saved in:
Bibliographic Details
Title: Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report.
Authors: Jóri B; Lungenkrebsmedizin, Oldenburg, Germany.; Institute for Hematopathology Hamburg, Hamburg, Germany., Bundschuh O; Gamma Knife Center, Hannover, Germany., Falk M; Institute for Hematopathology Hamburg, Hamburg, Germany., Heukamp LC; Lungenkrebsmedizin, Oldenburg, Germany.; Institute for Hematopathology Hamburg, Hamburg, Germany., Kluge A; Division of Radiology, Pius-Hospital, Oldenburg, Germany., Tiemann M; Institute for Hematopathology Hamburg, Hamburg, Germany., Willborn KC; Department of Radiation Therapy, Pius-Hospital, Oldenburg, Germany., Woitzik J; University Department of Neurosurgery, Evangelic Hospital Oldenburg, Oldenburg, Germany., Griesinger F; Lungenkrebsmedizin, Oldenburg, Germany.; Department of Internal Medicine-Oncology, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.; Department of Hematology and Oncology, Pius-Hospital, Oldenburg, Germany.
Source: Translational lung cancer research [Transl Lung Cancer Res] 2024 Jul 30; Vol. 13 (7), pp. 1749-1755. Date of Electronic Publication: 2024 Jul 15.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2218-6751
DOI:10.21037/tlcr-23-769